Dr. Reddy’s Laboratories announced the launch, in the U.S. market, of lenalidomide capsules, a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration. With this volume-limited launch, Dr.
PRINCETON, N.J. — Dr. Reddy’s Laboratories announced the launch, in the U.S. market, of lenalidomide capsules, a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration.
With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for lenalidomide capsules in 2.5 mg and 20 mg strengths.
In January 2025, Teva and Samsung Bioepis entered into a strategic partnership for the commercialization of EPYSQLI in the U.S. market.
Brian Newman has been named executive vice president and chief financial officer designate, effective April 21 and Dr. Amy Compton-Phillips will be the company’s new executive vice president and chief medical officer, effective May 19.
The initiative came in response to growing demand for care that acknowledges the specific challenges women face — from menopause and maternal mental health to heart health and healthy aging.
Rite Aid filed for Chapter 11 bankruptcy protection in October 2023. It emerged from bankruptcy as a private company.
In January 2025, Teva and Samsung Bioepis entered into a strategic partnership for the commercialization of EPYSQLI in the U.S. market.
This shift highlights an evolving consumer landscape where value, convenience, and occasion-based spending impact buying behavior, according to recent research by Circana.
The figure represents a significant increase from last year’s $22.4 billion and comes close to the record-setting $24 billion spent in 2023.
As part of this year’s campaign, comedian Beck Bennett steps into the role of the “Savings Whisperer,” sharing humorous insights on how to get the most out of Walmart+ during the promotional week.
